scholarly journals A phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy

2018 ◽  
Vol 29 ◽  
pp. viii190
Author(s):  
S.-H. Beom ◽  
K.-W. Lee ◽  
S.-H. Cho ◽  
Y.S. Park ◽  
T.W. Kim ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Standard Chemotherapy

Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer

1988 ◽  
Vol 24 (4) ◽  
pp. 801-802 ◽  
Author(s):  
Janke Greidanus ◽  
Pax H.B. Willemse ◽  
Dirk Th. Sleijfer ◽  
Nanno H. Mulder ◽  
RenéC.J. Verschueren ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Continuous Infusion ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Infusion Schedule

A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

2014 ◽  
Vol 37 (1) ◽  
pp. 19-23 ◽  
Author(s):  
Yong Sang Hong ◽  
Sung Sook Lee ◽  
Kyu-pyo Kim ◽  
Jae-Lyun Lee ◽  
Yoon-Koo Kang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study

A Phase II Study of Cetuximab/Irinotecan in Patients with Heavily Pretreated Metastatic Colorectal Cancer: Predictive Value of Early Specific Toxicities

2008 ◽  
Vol 7 (4) ◽  
pp. 273-279 ◽  
Author(s):  
Teresa Gamucci ◽  
Fabrizio Nelli ◽  
Giovanni Cianci ◽  
Giulia Grassi ◽  
Luca Moscetti ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Predictive Value ◽  
Phase Ii Study ◽  
Heavily Pretreated
Sign in / Sign up

Export Citation Format

Share Document